ARCA biopharma
Genetically-targeted therapies for cardiovascular diseases.
Launch date
Employees
Market cap
$55.3m
Enterprise valuation
$22m (Public information from Aug 2024)
Share price
$28.8 ABIO
Westminster Colorado (HQ)
Authorizing premium user...